Cite Filings / MRK / 0001628280-23-015990
Feed Companies Filings Check
Sign in
10-Q

Quarterly Report

Merck & Co., Inc. · Filed 2023-05-05 · Acc 0001628280-23-015990

Documents 1

  • 10-Q Quarterly Report , mrk-20230331.htm

Around this filing

  • 2023-08-07 10-Q Quarterly Report
  • 2023-05-05 10-Q Quarterly Report
  • 2023-05-05 4 EVP, General Counsel sold 19,141 shares at $117.59 ($2,250,834)
  • 2023-05-05 4 President, U.S. Market acquired 907 shares (option exercise)
  • 2023-05-05 4 EVP - Chief Strategy Officer acquired 885 shares (option exercise)
  • 2023-05-05 4 SVP Chief Ethics & Com Officer acquired 1,502 shares (option exercise)
  • 2022-11-03 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading mrk-20230331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…